Joel R. Hardink - Pfizer Worldwide Res & Dev, Pfizer Inc

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 14 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

An MMP13-Selective Inhibitor Delays Primary Tumor Growth and the Onset of Tumor-Associated Osteolytic Lesions in Experimental Models of Breast Cancer

Manisha Shah,Dexing Huang,Tony Blick,Andrea Connor,Lawrence A. Reiter,Joel R. Hardink,Conor C. Lynch,Mark Waltham,Erik W. Thompson

semanticscholar（2012）

Cited58Views0WOSBibtex

Targeting MMP13 in human breast cancer metastasis to bone

Manisha Shah,Tony Blick,Dexing Huang, Larry A. Reiter,Joel R. Hardink,Mark Waltham,Erik W. Thompson

CLINICAL & EXPERIMENTAL METASTASIS（2011）

Cited0Views0Bibtex

Potent Pyrimidinetrione-Based Inhibitors of MMP-13 with Enhanced Selectivity over MMP-14

JA Blagg,MC Noe, LA Wolf-Gouveia,LA Reiter,ER Laird, SPP Chang,D Danley,JT Downs, NC Elliott,JD Eskra,RJ Griffiths,JR Hardink, AI Haugeto,CS Jones,JL Liras,LL Lopresti-Morrow,PG Mitchell, J Pandit,RP Robinson, C Subramanyam, ML Vaughn-Bowser,SA Yocum

ChemInform（2005）

Cited63Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn